Data shared at ATTD 2024 in Florence, Italy, included the largest set of data from early users in the U.S. Results built upon three-year data from more than 100,000 real-world users who outperformed international time in range targets.
Medtronic’s MiniMed 780G, its latest-generation automated insulin delivery system, won FDA approval in April 2023. The current iteration uses the latest Guardian 4 technology and requires no fingersticks while in “SmartGuard” mode. It provides meal detection technology providing automatic adjustments and corrections to sugar levels every five minutes. This occurs for both basal (background) and bolus (mealtime) insulin needs.
MiniMed 780G with Guardian 4 offers insulin to account for when users forget to bolus or underestimate the number of carbs in their meal. Medtronic also has a newer version on the way, with the system garnering CE mark with the next-generation Simplera Sync sensor in January.
Get the full story at our sister site, Drug Delivery Business News.
